Literature DB >> 24678112

In vitro effect of D-004, a lipid extract of the fruit of the cuban royal palm (Roystonea regia), on prostate steroid 5α-reductase activity.

L Yohani Pérez1, Roberto Menéndez1, Rosa Má1, Rosa M González1.   

Abstract

BACKGROUND: D-004, a lipid extract of the fruit of the Cuban royal palm (Roystonea regia), has been found to reduce prostatic hyperplasia (PH) induced with testosterone (T), but not PH induced with dihydrotestosterone (DHT), in rodents, suggesting the inhibition of prostate 5α-reductase activity.
OBJECTIVES: The aims of this study were to assess whether D-004 inhibits prostate 5α-reductase activity in vitro and to examine the effects of D-004 on enzyme kinetics.
METHODS: This experimental study was conducted at the Pharmacology Department, Center of Natural Products, National Center for Scientific Research, Havana, Cuba. Soluble rat prostate preparations were used as the source of 5α-reductase, and ((3)H)-DHT production was measured to determine prostate 5α-reductase activity. Cell-free rat prostate homogenates were pre-incubated with carboxymethyl cellulose 2% alone (control tubes) or D-004 (0.24-125 μg/mL) suspended in the vehicle (treated tubes) for 10 minutes prior to adding the labeled substrate ((3)H)-T Once the reaction was stopped, sterols were extracted with chloroform and aliquots were applied on silica gel plates developed in benzene-acetone (4:1, v/v). Areas containing DHT were scraped and radioactivity was counted. The median inhibitory concentration (IC50) was determined by measuring the conversion of T to DHT The apparent Michaelis-Menten constant (Km) and Vmax values before and after adding D-004 were determined in kinetic studies using labeled T (0.5-25 μmol/L).
RESULTS: Compared with controls, D-004 significantly and dose-dependently inhibited the enzymatic reaction at doses of 1.95 to 125.0 μg/mL) (all, P < 0.05). The IC50 of D-004 required to inhibit 5a-reductase activity was 2.25 μg/mL. Enzyme inhibition was noncompetitive, since D-004 lowered the Vmax from 15.3 to 10.0 nmol DHT/min · mg(-1) protein, while the Km (4.54 μmol/L) was almost unaffected.
CONCLUSIONS: D-004 dose-dependently and noncompetitively inhibited in vitro 5α-reductase activity in soluble fractions of rat prostate. Although the extent of the maximal inhibition was high and the value of IC50 was low, the relevance of such inhibition requires further study in vivo.

Entities:  

Keywords:  D-004; free fatty acids; prostate 5α-reductase inhibitors; prostate hyperplasia

Year:  2006        PMID: 24678112      PMCID: PMC3965969          DOI: 10.1016/j.curtheres.2006.12.004

Source DB:  PubMed          Journal:  Curr Ther Res Clin Exp        ISSN: 0011-393X


  35 in total

Review 1.  Benign prostatic hyperplasia.

Authors:  M J Barry; C G Roehrborn
Journal:  BMJ       Date:  2001-11-03

2.  Serenoa repens (Permixon) inhibits the 5alpha-reductase activity of human prostate cancer cell lines without interfering with PSA expression.

Authors:  Fouad K Habib; Margaret Ross; Clement K H Ho; Valerie Lyons; Karen Chapman
Journal:  Int J Cancer       Date:  2005-03-20       Impact factor: 7.396

3.  Alpha 1-adrenoceptor subtypes in the human cardiovascular and urogenital systems.

Authors:  M C Michel; K Taguchi; R S Schäfers; T J Williams; D E Clarke; A P Ford
Journal:  Adv Pharmacol       Date:  1998

4.  A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples.

Authors:  M A Markwell; S M Haas; L L Bieber; N E Tolbert
Journal:  Anal Biochem       Date:  1978-06-15       Impact factor: 3.365

Review 5.  Benign prostatic hyperplasia.

Authors:  R J Simpson
Journal:  Br J Gen Pract       Date:  1997-04       Impact factor: 5.386

6.  Effects of D-004, a lipid extract from Cuban royal palm fruit, on inhibiting prostatic hypertrophy induced with testosterone or dihydrotestosterone in a rat model: A randomized, controlled study.

Authors:  Daisy Carbajal; Maria de Lourdes Arruzazabala; Más Rosa; Vivian Molina; Eduardo Rodríguez; Victor González
Journal:  Curr Ther Res Clin Exp       Date:  2004-11

7.  [Five-year experience in treating patients with prostatic hyperplasia patients with permixone (Serenoa repens "Pierre Fabre Medicament)].

Authors:  Iu G Aliaev; A Z Vinarov; K L Lokshin; L G Spivak
Journal:  Urologiia       Date:  2002 Jan-Feb

8.  Serenoa repens extract for benign prostate hyperplasia: a randomized controlled trial.

Authors:  K E Willetts; M S Clements; S Champion; S Ehsman; J A Eden
Journal:  BJU Int       Date:  2003-08       Impact factor: 5.588

9.  Comparison of finasteride (Proscar), a 5 alpha reductase inhibitor, and various commercial plant extracts in in vitro and in vivo 5 alpha reductase inhibition.

Authors:  L Rhodes; R L Primka; C Berman; G Vergult; M Gabriel; M Pierre-Malice; B Gibelin
Journal:  Prostate       Date:  1993       Impact factor: 4.104

10.  [Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study].

Authors:  Frans Debruyne; Gary Koch; Peter Boyle; Fernando Calais Da Silva; Jay G Gillenwater; Freddie C Hamdy; Paul Perrin; Pierre Teillac; Remigio Vela-Navarrete; Jean-Pierre Raynaud
Journal:  Prog Urol       Date:  2002-06       Impact factor: 0.915

View more
  5 in total

1.  Antioxidant effects of D-004, a lipid extract from the Roystonea regia fruit, on the plasma of healthy men.

Authors:  Ernesto López; Vivian Molina; José Illnait; Ambar Oyarzábal; Lilia C Fernández; Rosa Más; Rafael Gámez; Julio C Fernández; Sonia Jiménez; Meilis Mesa; Ivón Hollands; Sarahí Mendoza
Journal:  Asian J Androl       Date:  2009-01-26       Impact factor: 3.285

2.  Effects of D-004, a lipid extract of the fruit of the Cuban royal palm (Roystonea regia) or the lipidosterolic extract of saw palmetto (Serenoa repens) on the sexual activity in male rats: A controlled, experimental study.

Authors:  Lilia C Fernández; Rosa Mas; Julio Fernández; Sarahí Mendoza; Rafael Gámez; Balia Pardo
Journal:  Curr Ther Res Clin Exp       Date:  2008-02

3.  Efficacy and tolerability of Roystonea regia lipid extract (D-004) and terazosin in men with symptomatic benign prostatic hyperplasia: a 6-month study.

Authors:  Raúl Guzmán; Julio C Fernández; Manuel Pedroso; Lilia Fernández; José Illnait; Sarahí Mendoza; Ana T Quiala; Zunilda Rodríguez; Jilma Mena; Aylim Rodíguez; Marbelis Campos; Carlos Sánchez; Yanet Alvarez; Gladys Jiménez
Journal:  Ther Adv Urol       Date:  2019-06-11

4.  Analysis of Hydroxy Fatty Acids from the Pollen of Brassica campestris L. var. oleifera DC. by UPLC-MS/MS.

Authors:  Nian-Yun Yang; Yi-Fang Yang; Kun Li
Journal:  J Pharm (Cairo)       Date:  2012-10-10

5.  D-004 ameliorates phenylephrine-induced urodynamic changes and increased prostate and bladder oxidative stress in rats.

Authors:  Ambar Oyarzábal; Yohani Pérez; Vivian Molina; Rosa Mas; Yazmin Ravelo; Sonia Jiménez
Journal:  Transl Androl Urol       Date:  2015-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.